Luminex Corp. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
7,096.00
39,043.00
36,861.00
13,814.00
29,423.00
18,508
Depreciation, Depletion & Amortization
15,922.00
14,205.00
13,744.00
20,131.00
22,641.00
23,674
Other Funds
2,569.00
287.00
10.00
-
-
11,587
Funds from Operations
26,506.00
56,630.00
55,959.00
48,279.00
73,420.00
61,928
Changes in Working Capital
396.00
7,379.00
180.00
1,402.00
15,989.00
11,029
Net Operating Cash Flow
26,902.00
49,251.00
55,779.00
49,681.00
57,431.00
50,899
Capital Expenditures
19,018.00
17,142.00
19,558.00
13,330.00
14,775.00
Sale of Fixed Assets & Businesses
-
-
-
45.00
62.00
Purchase/Sale of Investments
12,123.00
11,490.00
3,488.00
18,491.00
1,000.00
Net Investing Cash Flow
2,703.00
28,534.00
22,153.00
62,892.00
17,113.00
Cash Dividends Paid - Total
-
-
-
-
7,930.00
Issuance/Reduction of Debt, Net
1,105.00
1,621.00
-
25,000.00
-
Net Financing Cash Flow
4,415.00
3,412.00
3,128.00
21,630.00
5,975.00
Net Change in Cash
25,135.00
23,770.00
36,852.00
35,094.00
33,660.00
Free Cash Flow
8,814.00
32,173.00
37,073.00
36,551.00
42,796.00
Deferred Taxes & Investment Tax Credit
551.00
8,549.00
5,624.00
3,626.00
6,383.00
8,159
Net Assets from Acquisitions
-
-
-
68,098.00
-
Other Sources
9,598.00
98.00
893.00
-
-
Change in Capital Stock
5,879.00
4,746.00
3,118.00
3,370.00
1,955.00
Exchange Rate Effect
55.00
359.00
98.00
253.00
683.00
Other Uses
-
-
-
-
1,400.00

About Luminex

View Profile
Address
12212 Technology Boulevard
Austin Texas 78727
United States
Employees -
Website http://www.luminexcorp.com
Updated 07/08/2019
Luminex Corp. develops, manufactures and markets proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries. The company was founded by Mark B. Chandler and Van S.